Found: 24
Select item for more details and to access through your institution.
Diffuse Cystic Metastases in the Lung after Nivolumab Treatment in a Patient with Non-Small Cell Lung Cancer: A Case Report.
- Published in:
- Case Reports in Oncology, 2021, v. 14, n. 1, p. 34, doi. 10.1159/000513426
- By:
- Publication type:
- Article
Successful Treatment of Combined Large Cell Neuroendocrine Carcinoma Harboring an EGFR Mutation with EGFR-TKIs plus Bevacizumab: A Case Report.
- Published in:
- Case Reports in Oncology, 2020, v. 13, n. 3, p. 1387, doi. 10.1159/000511112
- By:
- Publication type:
- Article
Nivolumab-related severe thrombocytopenia in a patient with relapsed lung adenocarcinoma: a case report and review of the literature.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Ectopic adrenocorticotropic hormone‐secreting carcinoid with solitary cryptococcosis in the lungs.
- Published in:
- Cancer Reports, 2022, v. 5, n. 11, p. 1, doi. 10.1002/cnr2.1731
- By:
- Publication type:
- Article
Tumor β-catenin expression is associated with immune evasion in non-small cell lung cancer with high tumor mutation burden.
- Published in:
- Oncology Letters, 2021, v. 21, n. 3, p. N.PAG, doi. 10.3892/ol.2021.12464
- By:
- Publication type:
- Article
Genetic alterations in epidermal growth factor receptor-tyrosine kinase inhibitor-naive non-small cell lung carcinoma.
- Published in:
- Oncology Letters, 2020, v. 19, n. 6, p. 4169, doi. 10.3892/ol.2020.11524
- By:
- Publication type:
- Article
Family with sequence similarity 83, member B is a predictor of poor prognosis and a potential therapeutic target for lung adenocarcinoma expressing wild-type epidermal growth factor receptor.
- Published in:
- Oncology Letters, 2018, v. 15, n. 2, p. 1549, doi. 10.3892/ol.2017.7517
- By:
- Publication type:
- Article
Efficacy and tolerability of nanoparticle albumin-bound paclitaxel in combination with carboplatin as a late-phase chemotherapy for recurrent and advanced non-small-cell lung cancer: A multi-center study of the Fukushima lung cancer association group of surgeons
- Published in:
- Oncology Letters, 2017, v. 13, n. 6, p. 4315, doi. 10.3892/ol.2017.5998
- By:
- Publication type:
- Article
Thoracoscopic resection of posterior mediastinal paraganglioma: perioperative management and surgical tips.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A case of discordant histology and expression of programmed death ligand 1 between primary tumor and brain metastases in adenosquamous carcinoma of the lung.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 26, p. 2707, doi. 10.1111/1759-7714.15061
- By:
- Publication type:
- Article
Lung adenocarcinoma coexisting with diffuse idiopathic pulmonary neuroendocrine cell hyperplasia manifesting as multiple pulmonary nodules: A case report.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 21, p. 3076, doi. 10.1111/1759-7714.14662
- By:
- Publication type:
- Article
Large cell neuroendocrine carcinoma of the lung controlled for 4 years by a single administration of pembrolizumab: A case report.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 19, p. 2817, doi. 10.1111/1759-7714.14615
- By:
- Publication type:
- Article
Multiple therapeutic peptide vaccines consisting of combined novel cancer testis antigens and anti-angiogenic peptides for patients with non-small cell lung cancer.
- Published in:
- Journal of Translational Medicine, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-97
- By:
- Publication type:
- Article
Multiple therapeutic peptide vaccines consisting of combined novel cancer testis antigens and anti-angiogenic peptides for patients with non-small cell lung cancer.
- Published in:
- 2013
- By:
- Publication type:
- journal article
CLDN15 is a novel diagnostic marker for malignant pleural mesothelioma.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-91464-0
- By:
- Publication type:
- Article
A patient with ALK‐positive lung adenocarcinoma who survived alectinib‐refractory postoperative recurrence for 4 years by switching to ceritinib.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 15, p. 2225, doi. 10.1111/1759-7714.14058
- By:
- Publication type:
- Article
Pulmonary large cell carcinoma, highly positive for PD‐L1, shows marked response to pembrolizumab: A case report.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 7, p. 1141, doi. 10.1111/1759-7714.13850
- By:
- Publication type:
- Article
Prognostic Impact of Hypoxia-Inducible miRNA-210 in Patients with Lung Adenocarcinoma.
- Published in:
- Journal of Oncology, 2015, v. 2015, p. 1, doi. 10.1155/2015/316745
- By:
- Publication type:
- Article
The clinical significance of tertiary lymphoid structure and its relationship with peripheral blood characteristics in patients with surgically resected non-small cell lung cancer: a single-center, retrospective study.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 5, p. 1129, doi. 10.1007/s00262-021-03067-3
- By:
- Publication type:
- Article
Tumor mutation burden and immunological, genomic, and clinicopathological factors as biomarkers for checkpoint inhibitor treatment of patients with non-small-cell lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 1, p. 127, doi. 10.1007/s00262-019-02446-1
- By:
- Publication type:
- Article
Wnt/β-Catenin Signaling and Resistance to Immune Checkpoint Inhibitors: From Non-Small-Cell Lung Cancer to Other Cancers.
- Published in:
- Biomedicines, 2023, v. 11, n. 1, p. 190, doi. 10.3390/biomedicines11010190
- By:
- Publication type:
- Article
The efficacy of the Kampo medicine rikkunshito for chemotherapy-induced anorexia (RICH trial): study protocol for a randomized controlled trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Prognostic impact of serum transthyretin in patients with non-small cell lung cancer.
- Published in:
- Molecular & Clinical Oncology, 2019, v. 10, n. 6, p. 597
- By:
- Publication type:
- Article
Neoadjuvant nivolumab plus chemotherapy in resectable non‐small‐cell lung cancer in Japanese patients from CheckMate 816.
- Published in:
- Cancer Science, 2024, v. 115, n. 2, p. 540, doi. 10.1111/cas.16030
- By:
- Publication type:
- Article